Featured Research

from universities, journals, and other organizations

New genomic marker for tuberculosis may help identify patients who will develop the disease

Date:
August 31, 2010
Source:
Nationwide Children's Hospital
Summary:
It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease.

It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease. These findings are from an international study published in the August 19 issue of Nature and conducted by doctors and researchers at Nationwide Children's Hospital using blood profiling techniques to understand infections.

Tuberculosis (TB) is caused by the bacterium Mycobacterium tuberculosis, which usually attacks the lungs and can be fatal if not treated properly. Although TB is no longer a leading cause of death in the United States, it remains an epidemic in much of the world. One third of the world's total population is infected with the microbes that cause TB; however, most people infected with M. tuberculosis remain asymptomatic with latent TB. People with latent TB have a 10 percent lifetime risk of developing active TB, but current tests can not identify which individuals will develop the disease.

"Tools to diagnose infections like TB, bronchiolitis and pneumonia have been developed and are actively used to classify patients as being infected with specific pathogens, but we are still unable to predict how each person is going to react to the infection," said one of the study's authors Octavio Ramilo, MD, chief of Infectious Diseases at Nationwide Children's Hospital. "It's difficult to predict patient outcomes, and this is a real problem."

To combat this problem, Dr. Ramilo and Asuncion Mejias, MD, investigators at the Center for Vaccines and Immunity in The Research Institute at Nationwide Children's Hospital, are using microarray technology to develop blood profiles in patients specific to infectious diseases.

"Each infectious agent, be it a virus or a bacterium, interacts with human immune cells in unique ways by triggering proteins on white blood cells," said Dr. Mejias. "We can identify patterns among the white blood cell's activated proteins and identify a unique 'signature' for each infectious agent."

Drs. Ramilo and Mejias' -- also faculty members at The Ohio State University College of Medicine -- research has shown that gene expression microarray technology can be used to help develop blood transcriptional signatures.

"This technology allows us to see the whole picture of infection using a single blood sample, which is a really powerful tool for the clinic," said Dr. Mejias.

It's this gene expression microarray technology that allowed an international group of investigators, of which Drs. Ramilo and Mejias are part of, to provide the first complete description of the blood transcriptional signature of TB.

The study examined and compared blood drawn from patients in London, England and Cape Town, South Africa who had active TB, latent TB or who did not have TB. The team developed genome-wide transcriptional profiles for each of the patients and discovered a distinct characteristic, or "signature," of the blood from patients with active TB. X-rays of patients with this signature were consistent with signs of active TB.

"The study shows for the first time that the transcriptional signature in blood correlates with extent of disease in active TB patients," said Dr. Ramilo. "It validates the idea that this transcriptional signature is an accurate marker of TB infection."

The team also found that a subset of latent TB patients had signatures similar to those in active TB patients.

"The signature of active TB, which was observed in 10 to 20 percent of latent TB patients, may identify those individuals who will develop disease, but longitudinal studies are needed to assess this," said Dr. Ramilo.

The transcriptional signature was diminished in active TB patients after two months and completely extinguished by 12 months after treatment.

"These findings suggest that the blood transcriptional signature of active TB patients could be used to monitor how well a patient's treatment is working," said Dr. Ramilo.

Dr. Mejias says that this study highlights the power that gene expression microarray technology could bring to the diagnosis and treatment of infectious diseases, as the blood transcriptional signatures are not limited to TB. Currently, the infectious disease investigators at Nationwide Children's Hospital are developing transcriptional signatures using blood samples obtained from children with broncholitis and pneumonia and plan to correlate findings with clinical outcomes, similar to the recent TB study.

"It seems that we are developing a tool that can not only diagnose infectious diseases, but also indicate severity and eventually predict which patients are at risk for developing advanced symptoms. These capabilities are desperately needed in order to improve how patients recover from infections," said Dr. Ramilo.


Story Source:

The above story is based on materials provided by Nationwide Children's Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Matthew P. R. Berry, Christine M. Graham, Finlay W. McNab, Zhaohui Xu, Susannah A. A. Bloch, Tolu Oni, Katalin A. Wilkinson, Romain Banchereau, Jason Skinner, Robert J. Wilkinson, Charles Quinn, Derek Blankenship, Ranju Dhawan, John J. Cush, Asuncion Mejias, Octavio Ramilo, Onn M. Kon, Virginia Pascual, Jacques Banchereau, Damien Chaussabel, Anne O’Garra. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 2010; 466 (7309): 973 DOI: 10.1038/nature09247

Cite This Page:

Nationwide Children's Hospital. "New genomic marker for tuberculosis may help identify patients who will develop the disease." ScienceDaily. ScienceDaily, 31 August 2010. <www.sciencedaily.com/releases/2010/08/100830073801.htm>.
Nationwide Children's Hospital. (2010, August 31). New genomic marker for tuberculosis may help identify patients who will develop the disease. ScienceDaily. Retrieved August 28, 2014 from www.sciencedaily.com/releases/2010/08/100830073801.htm
Nationwide Children's Hospital. "New genomic marker for tuberculosis may help identify patients who will develop the disease." ScienceDaily. www.sciencedaily.com/releases/2010/08/100830073801.htm (accessed August 28, 2014).

Share This




More Health & Medicine News

Thursday, August 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mini Pacemaker Has No Wires

Mini Pacemaker Has No Wires

Ivanhoe (Aug. 27, 2014) Cardiac experts are testing a new experimental device designed to eliminate major surgery and still keep the heart on track. Video provided by Ivanhoe
Powered by NewsLook.com
After Cancer: Rebuilding Breasts With Fat

After Cancer: Rebuilding Breasts With Fat

Ivanhoe (Aug. 27, 2014) More than 269 million women are diagnosed with breast cancer each year. Many of them will need surgery and radiation, but there’s a new simple way to reconstruct tissue using a patient’s own fat. Video provided by Ivanhoe
Powered by NewsLook.com
Blood Clots in Kids

Blood Clots in Kids

Ivanhoe (Aug. 27, 2014) Every year, up to 200,000 Americans die from a blood clot that travels to their lungs. You’ve heard about clots in adults, but new research shows kids can get them too. Video provided by Ivanhoe
Powered by NewsLook.com
Radio Waves Knock out Knee Pain

Radio Waves Knock out Knee Pain

Ivanhoe (Aug. 27, 2014) Doctors have used radio frequency ablation or RFA to reduce neck and back pain for years. But now, that same technique is providing longer-term relief for patients with severe knee pain. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins